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LETTER TO THE EDITOR 
 
Intrafamily Transmission of HCV Need to More  
Discussion 
 
 
Dear Editor, 
Chronic hepatitis C virus (HCV) infection is the ma-
jor cause of liver disease related to high morbidity 
and mortality in hemophilic patients who needs regu-
lar blood product administration.
1 Although genotype 
of infecting HCV is one of the prime predictors of 
response to antiviral therapy,
2 however, its distribu-
tion in hemophilic patients is still unclear.
3   
The article titled; Distribution of hepatitis C virus 
genotypes in Iranian patients with congenital bleeding 
disorders, revealed the genotype distribution of HCV 
in Iranian hemophilic patients.
4 In this study, results 
demonstrate genotype 1a was the most frequent HCV 
genotype  (58%),  followed  by  genotype  3a  (18.5%) 
and genotype 1b (14.7%). Mixed genotypes were also 
detected  in  6.2%.  These  findings  were  compatible 
with other similar studies on HCV infected patients in 
Iran. In USA and Western Europe, HCV genotypes 
1a and 3 are more predominant, 1b and 2 in South 
Europe and genotype 4 in Africa and Middle East.
5 
This pattern of HCV genotypes in Iranian hemophilic 
patients is similar to which of Western Europe and 
different to which of neighbor countries. 
This work has enriched the data of genotype dis-
tribution in different areas. Nevertheless, genotype is 
an important parameter used in selecting an antiviral 
therapy and genotyping and subtyping of HCV is rel-
evant to the epidemiology of HCV, I believe this arti-
cle may give some suggestive help in clinical man-
agement against chronic HCV infection. 
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